Anuh Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anuh Pharma has submitted a routine regulatory certificate to the stock exchanges for the quarter ended 31st December 2025. The certificate was issued by the company's Registrar and Share Transfer Agent, Bigshare Services Private Limited, under SEBI Regulation 74(5). It confirms that the company did not receive any dematerialization requests (i.e., requests to convert physical share certificates into electronic/demat form) from shareholders during the October–December 2025 quarter. This is a standard quarterly compliance filing required by SEBI for all listed companies whose shares are held in dematerialized form.
No material impact on shareholders or the stock. This is a purely procedural compliance filing with no business or financial information disclosed, and reflects normal share transfer agent activity.